Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,722
Out of 4,827 analysts
6
Total ratings
n/a
Success rate
-36.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $2.15 | -6.98% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $53.23 | +78.47% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $87.50 | +42.86% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $5.01 | +99.60% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $16.41 | -8.59% | 1 | Nov 11, 2022 | |
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $2.15
Upside: -6.98%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $53.23
Upside: +78.47%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $87.50
Upside: +42.86%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $5.01
Upside: +99.60%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $16.41
Upside: -8.59%